| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/10/2001 | US6213930 Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
| 04/10/2001 | CA2217729C Substance fa-70d, process for producing the same, and uses thereof |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2152075C Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 04/10/2001 | CA2140543C Thrombin receptor antagonists |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2123787C Method of treating non-streptococcal bacterial infections |
| 04/10/2001 | CA2081150C Use of antibody-containing preparations for immunosuppression |
| 04/10/2001 | CA2076901C Kainate-binding, human cns receptors of the eaa2 family |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/10/2001 | CA2067233C Fibronectin binding peptide |
| 04/10/2001 | CA2046861C K2p pro stabilisation |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/05/2001 | WO2001023615A1 Anti-aging nucleic acid and protein targets |
| 04/05/2001 | WO2001023599A1 Streptococcus pneumoniae ykqc |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023592A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023589A2 23431, a novel human ubiquitin protease |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023587A2 Serine protease |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023573A1 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023569A1 Cytokine receptor materials and methods |
| 04/05/2001 | WO2001023568A2 Members of the iap gene family |
| 04/05/2001 | WO2001023566A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
| 04/05/2001 | WO2001023564A1 Secreted factors |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023562A2 Osteoprotegerin regulatory region |
| 04/05/2001 | WO2001023560A2 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 04/05/2001 | WO2001023558A2 Human secretory molecules |
| 04/05/2001 | WO2001023557A1 Novel polypeptides and genes encoding the same |
| 04/05/2001 | WO2001023555A1 Method of prolonging normal cell life span |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023553A2 Metastasis-associated antigen c4.4a |
| 04/05/2001 | WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023538A2 Molecules for disease detection and treatment |
| 04/05/2001 | WO2001023529A1 Bioengineered collagen fibrils |
| 04/05/2001 | WO2001023523A2 Secreted proteins and uses thereof |
| 04/05/2001 | WO2001023522A2 Compositions and methods for p53-mediated repression of gene expression |
| 04/05/2001 | WO2001023521A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023431A1 Derivatives of antibody against ganglioside gm2 |
| 04/05/2001 | WO2001023430A2 Human chitinase immunoglobulin fusion proteins |
| 04/05/2001 | WO2001023429A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 04/05/2001 | WO2001023428A2 Interleukin-2 receptor associated polypeptides |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023423A1 A novel gene encodes the human huntingtin interacting polypeptide which comprises the ww domain and its producing method and application |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023420A2 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023006A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | WO2001023003A1 Tissue flap angiogenesis |
| 04/05/2001 | WO2001022991A1 Acth treatment of steroid- and statin-treated patients |
| 04/05/2001 | WO2001022990A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 04/05/2001 | WO2001022989A2 Method to enhance healing of sternum after sternotomy |
| 04/05/2001 | WO2001022988A1 ESTROGEN RELATED RECEPTOR, ERRα, A REGULATOR OF BONE FORMATION |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022986A1 Anti cancer agent and method of treatment of cancer |
| 04/05/2001 | WO2001022985A1 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
| 04/05/2001 | WO2001022984A1 Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
| 04/05/2001 | WO2001022983A2 Viscosity modulating substance and use thereof |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022970A1 Therapy with 2-5a and interferon |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001022921A2 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| 04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
| 04/05/2001 | WO2001022837A1 Composition comprising casein protein and whey protein |
| 04/05/2001 | WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000076455A3 Chicken growth hormone releasing hormone receptor |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000072867A3 Substantially oil-free cyclosporin compositions |
| 04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
| 04/05/2001 | WO2000069914A3 Humanized antibodies specific for egp-2 |
| 04/05/2001 | WO2000066782A3 Diagnostic assay for diabetes mellitus based on mutational burden |
| 04/05/2001 | WO2000066752A3 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide |
| 04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 04/05/2001 | WO2000061738A3 Differential regulation of gene expression in oncogenic transformation |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000053738A8 Methods and compositions for regulating memory consolidation |
| 04/05/2001 | WO2000052205A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 04/05/2001 | WO2000050064A3 Synergistic combination for treatment of viral-mediated diseases |
| 04/05/2001 | WO2000031254A9 Apoptosis-inducing factor |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |